Stock Watch - Stock pick — Intel and Merck
--:--
Deryck Janse van Rensburg from Anchor chose Intel as his stock pick of the day and Nick Crail from Asburton Investments chose Merck.
Janse van Rensburg said: "My pick is Intel, it's a very well know worldwide brand and it's obviously been in the tech industry for many many years. The company suffered for quite some time as we saw this big tick up and as they adapted to the environment that we are exposed to and that we know today. There is a little bit of a reject going on in the company at the moment where there's a new CEO coming in and I certainly think he's going to bring a little bit of flair to the company that's going to give it a different trajectory and I'm looking forward to that.Crail said: "My stock pick is offshore, and it's a company that I think has taken a bit of a beating through the pandemic and they are 20% off where it was trading before the pandemic started. It is a large pharmaceutical company called Merck and it's listed in the US. They recently came out with a set of results that show that it probably, through the course of the pandemic lost around 5% of its top line due to the pandemic, but I think as we watch more and more of these vaccines happen, especially in the developed world and the world returning to normal, I think this is certainly a stock that can play a lot of catch up moving forward."
Janse van Rensburg said: "My pick is Intel, it's a very well know worldwide brand and it's obviously been in the tech industry for many many years. The company suffered for quite some time as we saw this big tick up and as they adapted to the environment that we are exposed to and that we know today. There is a little bit of a reject going on in the company at the moment where there's a new CEO coming in and I certainly think he's going to bring a little bit of flair to the company that's going to give it a different trajectory and I'm looking forward to that.Crail said: "My stock pick is offshore, and it's a company that I think has taken a bit of a beating through the pandemic and they are 20% off where it was trading before the pandemic started. It is a large pharmaceutical company called Merck and it's listed in the US. They recently came out with a set of results that show that it probably, through the course of the pandemic lost around 5% of its top line due to the pandemic, but I think as we watch more and more of these vaccines happen, especially in the developed world and the world returning to normal, I think this is certainly a stock that can play a lot of catch up moving forward."